RICI HEALTHCARE HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.1 HKD | -1.79% |
|
0.00% | -5.98% |
| 03-28 | Rici Healthcare Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-11 | Rici Healthcare’s Profit Forecast to Rise in 2023; Shares Up 3% | MT |
| Sales 2022 | 2.38B 328M 2.57B 448M | Sales 2023 | 2.99B 413M 3.23B 565M | Capitalization | 1.69B 233M 1.83B 319M |
|---|---|---|---|---|---|
| Net income 2022 | 291M 40.16M 314M 54.9M | Net income 2023 | 364M 50.24M 393M 68.68M | EV / Sales 2022 | 0.97 x |
| Net Debt 2022 | 1.58B 218M 1.71B 298M | Net Debt 2023 | 1.46B 201M 1.57B 275M | EV / Sales 2023 | 1.05 x |
| P/E ratio 2022 |
2.51
x | P/E ratio 2023 |
4.65
x | Employees | 9,413 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.72% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.79% | ||
| Current month | -4.35% | ||
| 1 month | -2.65% | ||
| 3 months | -1.79% | ||
| 6 months | +27.91% | ||
| Current year | -5.98% |
1 week
1.06
1.13
1 month
1.011.13
Current year
1.011.24
1 year
0.561.35
3 years
0.361.70
5 years
0.361.77
10 years
0.362.66
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Xin Fang
CEO | Chief Executive Officer | 59 | 16-02-02 |
Xiao Ying Lin
COO | Chief Operating Officer | 46 | - |
Hao Ze Fang
BRD | Director/Board Member | 35 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pei Xing Jiang
BRD | Director/Board Member | 56 | 17-06-05 |
Sze Wing Wong
BRD | Director/Board Member | 46 | 16-06-22 |
Yong Wang
BRD | Director/Board Member | 58 | 16-06-22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 1.1 | -1.79% | 20,000 |
| 24-04-25 | 1.12 | +0.90% | 102,000 |
| 24-04-24 | 1.11 | +0.91% | 958,000 |
| 24-04-23 | 1.1 | 0.00% | 0 |
| 24-04-22 | 1.1 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am
More quotes
RICI HEALTHCARE HOLDINGS LIMITED is principally engaged in the general hospital business, medical examination business and clinic business. The Company operates its general hospital business through Nantong Rich Hospital. The Medical Examination business is primarily involved in the provision of comprehensive medical examination business services. The Clinic Business is engaged in the management and operation of clinic business relating to a verity of specialties, internal medicine, surgery, obstetrics, gynecology, stomatology, rehabilitation, medical imaging, as well as clinical laboratory, among others. The Company mainly operates its business in China.
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.98% | 223M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 1526 Stock
